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A recombinant Escherichia coli K-12 strain, transformed with a modiﬁed bacterial luciferase gene
(luxABCDE) from Photorhabdus luminescens, was constructed in order to monitor the activity of
various antimicrobial agents on a real-time basis. This E. coli-lux emitted, without any addition of
substrate, constitutive bioluminescence (BL), which correlated to the number of viable bacterial
cells. The decrease in BL signal correlated to the number of killed bacterial cells. Antimicrobi-
al activity of hydrogen peroxide (H2O2) and myeloperoxidase (MPO) was assessed. In high con-
centrations, H2O2 alone had a bacteriocidic function and MPO enhanced this killing by forming
hypochlorous acid (HOCl). Taurine, the known HOCl scavenger, blocked the killing by MPO. When
E. coli-lux was incubated with neutrophils, similar killing kinetics was recorded as in H2O2/MPO
experiments. The opsonization of bacteria enhanced the killing, and the maximum rate of the MPO
release from lysosomes coincided with the onset of the killing.
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1. INTRODUCTION
Polymorphonuclear neutrophils are the most abundant type of white blood cells in mammals; they are the
key effector cells in the host defense response to microbial invasion providing the rapid deployment and
effector arm of the immune system [1–6]. Neutrophils are professional phagocytes capable for ingesting
microbes and particles into intracellular compartments called phagolysosomes.
An arsenal of cytotoxic agents in phagolysosomes is directed to degrade the phagocytosed material
[7–10]. The process of opsonization is a means of identifying the invading microbes by phagocytes. The
nonspeciﬁc binding of the complement component C3b and C3bi and the speciﬁc binding of the serum
antibodies to the invading pathogen are normally required for the successful recognition and destruction of
this pathogen by phagocytic cell [11–16].
The ingestion of the target leads to enhanced consumption of oxygen through the activity of NADPH
oxidase that generates superoxide anion (O2
−) which is further dismutated forming hydrogen peroxide
(H2O2)[ 6–10]. This leads to the formation of further reactive oxidants such as hypochlorous acid (HOCl)
catalyzed by myeloperoxidase (MPO) [6–9, 17]. MPO is a peroxidase enzyme having a fundamental role
in the oxidant production and thus in antimicrobial activity of neutrophils. It is a lysosomal protein stored
in azurophilic granules of the neutrophils [6–9]. MPO is released by fusing these granules with phagosome
leading to the formation of the phagolysosome [18].
The assessment of the antimicrobial activities of neutrophils is generally made by ﬂow cytometry
(FC), chemiluminescence (CL) assay, or microscopy [13, 19–23]. Moreover, the detection of MPO is
mainly based on the quantiﬁcation of the enzyme protein by immunoassays without any knowledge of
MPO activity. We have previously used luminol-ampliﬁed CL and FC to analyze the binding, ingestion and
respiratory burst activities of phagocytes [24–28], and there is a strict correlation between the number
of ingested particles and luminol-ampliﬁed CL response of neutrophils [23, 24], provided that the CL
of adhesion events is excluded [23, 24]. Luminol-ampliﬁed CL has been shown to be almost completely
dependent on the release of MPO from azurophilic granules.
These are reliable methods, but they do not reveal anything about the killing of the microbes.
Conventionally, viability assessment is made by plate counting. The kinetic measurement of killing by
this method is troublesome, and the results are not obtained on a real time basis, since the plates demand
a long incubation period. Optical density (OD) measurement also provides a real-time assay, but the high
cell density required for the turbidity measurements and an inability to distinguish between live and dead
bacteria restrict the application of this method [29].
In this study, we describe an approach in which Escherichia coli K-12 pEGFPluxABCDEAmp (E.
coli-lux) was utilized for the assessment of the killing by neutrophil-derived oxidants. We have previously
shown that the bioluminescence (BL) signal of E. coli-lux was directly related to the number of viable
bacterial cells and the diminishment of the signal, caused by the addition of antimicrobial agent, correlates
to the number of killed E. coli-lux cells [29]. We can monitor this killing reaction quantitatively on a real-
time basis by measuring the BL signal continuously during the incubation [29].
2. MATERIALS AND METHODS
2.1. Materials
Agar, tryptone, and yeast extract were obtained from Difco laboratories (Detroit, Mich). Disodium phos-
phate (Na2HPO4·2H2O) and monopotassium phosphate (KH2PO4) were purchased from J. T. Baker (De-
venter, Holland). Ampicillin sodium salt, glycerol, H2O2, luminol, sodium chloride (NaCl), and taurine
were obtained from Sigma-Aldrich (St. Louis, Mo, USA). MPO was purchased from Planta Natural Pro-
ducts (Vienna, Austria). All reagents were at least of analytical grade.
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2.2. Bacterial Preparation and Cultivation
E. coli-lux was precultivated in 5mL of Luria Bertani Broth (LB) (10g tryptone, 5g of yeast extract, 5g
NaCl, and pH 7.4) and incubated in a shaker (250rpm) at 37◦C overnight. Bacterial cultivation was then
suspended in 100mL LB medium and incubated in a shaker (250rpm) at 37◦C until OD620nm was 0.25,
measured with Shimadzu UV-1601 photometer (Shimadzu Corporation, Japan). At this OD, the cells were
in logarithmic growth, and the cultures contained approximately 3.5 × 107 bacterial cells/mL. The cells
were harvested by centrifugation at 2500×g, resuspended in the mixture of 20mL of LB (containing 25%
glycerol) for freezer stock to be stored at −70◦C. All E. coli media contained 100µg/mL ampicillin in order
to maintain the selection pressure.
Before killing experiments, E. coli-lux was ﬁrst cultivated by adding 50µL of freezer stock to 5mL
LB medium and then incubated in a shaker (250rpm) at 37◦C until OD620nm was 0.25. After incubation
bacterial cells were harvested by centrifugation at 2500×g, washed two times, and then resuspended either
in 67mM phosphate buffer (pH 7.4) with 0.9% sodium chloride (NaCl) or Hanks Balanced Salt Solution
(HBSS) with gelatin (1mg/mL) (gHBSS) for phagocytosis analysis.
2.3. Serum Handling and Leukocyte Separation
Peripheral human blood was collected from a healthy volunteer into Venosafe 3mL EDTA tube and one
Venosafe 4mL serum tube (Terumo Corporation, Leuven, Belgium). Serum was separated and used for the
opsonization. 1mL of EDTA blood was mixed with 10mL of 0.83% NH2Cl including 370mg/l EDTA
in order to lyse the red blood cells (RB). The suspension was kept at room temperature for 15min,
after which leukocytes were separated by centrifugation for 10min at 400×g. The lysed RB debris was
sucked away, and leukocytes were resuspended in 1mL of gHBSS. To avoid unnecessary stress to cells
additional puriﬁcation steps were refrained. Leukocytes were calculated with microscope by using B¨ urker
counting chamber, and isolated leukocyte suspension contained approximately 2.5 × 106 neutrophils/mL,
representing 85% of the phagocyte population (monocytes 12% and eosinophils 3%). We have previously
shown that the luminol-ampliﬁed CL response of monocytes and eosinophils is only 50% of that of
neutrophils and, thus, practically, the entire CL-signal per blood volume originates from neutrophils [25].
2.4. Antimicrobial Reaction of H2O2 and MPO
Killing assays were performed by adding 140µL of cultivated E. coli-lux bacteria suspended in phosphate
buffer (pH 7.4 with 0.9% NaCl), into the wells of a white clear bottom 96-well microtiter plate (Greiner Bio-
One,D¨ usseldorf,Germany),containing3×105 or3×106 bacterialcells/well.MPO(1or2µg/well),H2O2
(30µM, 125µM, 500µM, 2mM, or 20mM/well) and taurine (50mM/well) were all added separately in
20µL of phosphate buffer. The ﬁnal reaction volume was 200µL/well, and the reaction was started by
adding H2O2.
2.5. Killing Activity of Neutrophils
Neutrophils-killing activity assay was performed by pipetting 100µL of cultivated bacteria suspended in
gHBSS, containing 1 × 106 bacterial cells/well. Neutrophils were added by pipetting 2.5 × 105 neutrophils
in 100µL of gHBSS into the wells. Opsonization was performed by adding 40µL of 2.5% serum solution
in gHBSS to the reaction mixture, ﬁnal serum concentration being 0.4%. The ﬁnal reaction volume was
250µL/well.
Luminol-ampliﬁed CL assay was made by adding 100µL of bacterial suspension (1 × 106 E. coli-
lux cells/well) in gHBSS, 100µL of leukocyte suspension (2.5 × 105 neutrophils/well) in gHBSS, 20µLo f
luminol (10mM in borate buffer, pH 9.0), and 20µL of human serum solution in gHBSS to the microtiter
plate wells (ﬁnal serum concentration 0.4%). The ﬁnal reaction volume was 250µL/well.
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2.6. Multimode Readers
BL and OD (620nm) of E. coli-lux was measured in microtiter plate wells at 37◦Ci nM i t h r a sL B9 4 0
microplate reader (Berthold technologies, Bad Wildbad, Germany). Luminol-ampliﬁed CL signal was
measured in Chameleon microplate reader (Hidex, Turku, Finland), both controlled by MicroWin 2000
(Mikrotek). Three parallel wells were prepared from every reaction mixture. Readers were programmed to
measure luminescence and OD continuously 0.5sec/well, at 60 or 240sec interval. Background signal was
measured from a well containing only the buffer, and this reading was subtracted from the readings of the
experimental wells. Results are shown as the mean ± SD of three parallel wells.
2.7. Colony Forming Unit (CFU) Measurement
A duplicate microplate, similar to that placed into the multimode reader in H2O2/MPO and neutrophil
analysis, was placed into a laminar hood and incubated at 37◦C. At 30min intervals, 100µLo fe v e r y
reaction suspension was diluted 101–107-fold, and 100µL and 20µL from every dilution were pipetted
into Petri dishes containing LA agar with 100µg/mL ampicillin. Colonies were counted after overnight
incubation at 37◦C. Results are shown as CFU/reaction volume.
2.8. Data Handling
Raw data was analyzed in Excel version 2007 (Microsoft), and all graphs were prepared with Origin version
8 (Microcal).
3. RESULTS
3.1. H2O2 and MPO Activity
H2O2 and MPO were added into the E. coli-lux suspension (3 × 105 cells/well), and BL and CFU were
recorded (Figure 1). H2O2 alone, in the absence of MPO, had a capacity of killing, and more than 99% of
bacterial cells were killed by 500µMH 2O2 after 90min of incubation (Figures 1(a) and 1(b)). Addition of
MPO enhanced the killing substantially, since the addition of 1µg of MPO into 500µMH 2O2 killed more
than 99% of bacterial cells already after one minute of reaction (Figures 1(a) and 1(b)). This enhancement
was due to the HOCl generated by MPO reaction [7–10]. This was conﬁrmed by adding 50mM taurine, the
known HOCl scavenger [22, 30], which blocked the killing by MPO reaction nearly totally (Figure 1(a)).
That the BL measurement and plate counting were in accord with each other is shown in Table 1.
Bacteriolytic effect of the antimicrobial agent is detectable only by assessing the decrease in the
OD signal [31–33]. The OD detection limit of the used plate reader, for the bacterial suspension, was
approximately 1 × 106 cells/well corresponding to 0.030 OD in 200µL, and therefore 10-fold higher
bacterial cell number (3 × 106 cells/well) had to be used in killing experiments. The H2O2 concentrations
used in previous experiments were not high enough to show any decrease in OD. Only 2mM H2O2
in the presence of 2µgo fM P Oa n d2 0 m MH 2O2 in the absence of MPO showed a decrease in OD,
that is, bacteriolysis (Figure 2). In summary, the antimicrobial agents of neutrophils, H2O2, and HOCl
showed signiﬁcant killing capacity, which was easily measurable using E. coli-lux. These agents in high
concentrations were even able to lyse the bacterial cells.
3.2. Killing Activity of Neutrophils
When neutrophils, instead of H2O2 and MPO, were added to the reaction, similar killing curves (Figure 3)
were recorded as in previous experiments. It is noteworthy that neutrophils quenched partially BL since the
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FIGURE 1: The bioluminescence signal (a) and colony forming units (CFU)/200µL (b) of E. coli-lux (3 ×
105 cells) incubated in the presence of various amounts of H2O2 (µM) and 1µg/well MPO in phosphate
buffer at 37◦C. ()0 µM, (•)3 0 µM, () 125µM, () 500µM, ()M P O+0 µM, ( )M P O+3 0µM, (∇)
MPO + 125µM, (♦) MPO + 500µM, and () MPO + 50mM of taurine + 30µM. Relative luminescence unit
(RLU) values are shown as the mean ± SD of measurements from three parallel wells.
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FIGURE 2: The bioluminescence signal and optical density (OD) of E. coli-lux (3 × 106 cells) incubated in
the presence of various amounts of H2O2(mM) and 2µg/well MPO in phosphate buffer at 37◦C. RLU: ()
0mM, (•) MPO + 0mM, () 2mM, () MPO + 2mM, and () 20mM; OD620nm:( ) 0mM, ( ) MPO + 0mM,
() 2mM, (∇) MPO + 2mM, and (♦)2 0m Mo fH 2O2. Relative luminescence unit (RLU) and OD values are
shown as the mean ± SD of measurements from three parallel wells.
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TABLE 1: The killing capacity of the H2O2/MPO system. The killing capacity of the H2O2/MPO system, both
from the RLU and CFU analysis, was calculated by setting the values from the bacterial well as a 0% of
killing.
The killing capacity of the H2O2/MPO system
Killing (%)
0min 30min 60min 90min
RLU CFU RLU CFU RLU CFU RLU CFU
MPO 1µg/well 0 0 0 1.3 0 0 0 0.6
H2O2 30µM 29.4 15.8 81.1 77.2 82.9 60.3 46.0 29.3
H2O2 125µM 29.4 23.1 86.5 84.2 91.4 79.8 78.0 61.4
H2O2 500µM 69.1 80.6 98.6 98.0 99.5 98.8 99.9 99.6
H2O2 30µM+M P O1µg/well 72.9 79.5 97.6 97.2 99.1 98.0 99.6 98.7
H2O2 125µM+M P O1µg/well 82.4 89.0 100 99.6 100 100 100 100
H2O2 500µM+M P O1µg/well 93.2 96.0 100 100 100 100 100 100
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FIGURE 3: The bioluminescence signal (a) and colony forming units (CFU)/250µL (b) of E. coli-lux (1 ×
106 cells) incubated in the presence of 2.5 × 105 neutrophils and 0.4% serum for opsonization in gHBSS
medium at 37◦C: () bacteria, (•) bacteria + serum, () bacteria + neutrophils and () bacteria + neutrophils
+ serum. Relative luminescence unit (RLU) values are shown as the mean ± S.D. of measurements from
three parallel wells. Arrows point out the onset of the killing.
initial relative luminescence unit (RLU) value of bacteria was reduced by 40% instantly after adding 2.5 ×
105 neutrophils into the mixture. This was not killing since CFU values did not instantly decrease.
The actual killing of the microbes started approximately after 50–60min of incubation when E.
coli-lux was opsonized with 0.4% serum (OPS) and after 90–100min in the absence of opsonins (NOPS)
(Figures 3(a) and 3(b)).
Killing rate after 180min of measurement was 41% for NOPS and 96% for OPS measured by RLU
(Figure 3(a)) and 49% for NOPS and 92% for OPS measured by CFU (Figure 3(b)). Leukocytes were
disrupted to ﬁnd out whether the ingested bacteria were killed. Since there was no difference between the
disrupted samples and normal samples in RLU and CFU (data not shown), it was concluded that all the
ingested bacteria were killed.
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FIGURE 4: The luminol-ampliﬁed chemiluminescence (CL) signal of E. coli-lux (1 × 106 cells) with 2.5 ×
105 neutrophils and 0.4% serum in gHBSS medium at 37◦C. (•) bacteria + serum (OPS) and () bacteria
(NOPS). Counts per second (CPS) values are shown as the mean ± SD of measurements from four parallel
wells. Arrows point out the peak times of the CL signals.
Without neutrophils, the RLU signal was reduced by 4% in the presence of 0.4% serum (Figure 3(a)).
Thesamereductionin CFUwas75%(Figure 3(b)). Thediscrepancybetweenthesetwo valuesis thoroughly
studied in another paper [29].
When luminol-ampliﬁed CL was recorded in the same reaction conditions as BL and CFU, the time
to reach the maximum CL response (Figure 4) was the same as the time for the onset of killing (Figure 3).
4. DISCUSSION
E.coli-lux-basedreal-time BLmeasurementprovidesanewapproachforthebacterialkillingbyneutrophils
and also for the antimicrobial activity of MPO. The kinetics of the killing activity of the antimicrobial
agents can be continuously recorded; hence, the conventional kinetic parameters such as Vmax and Km can
be obtained. From the kinetic curves, even the absolute number of the killed bacterial cells can be derived.
It is obvious that the mechanisms of various scavenger and inhibitor functions, like taurine function in this
study, can be explored.
In the present work, RLU and CFU values were in general in good correlation. Two exceptions were
noticed. First, there was an initial reduction of 40% in RLU after the addition of neutrophils. This reduction
was not present in CFU measurements. We have noticed that the extent of this reduction is dependent on
the number of neutrophils added, even if they were heat inactivated (data not shown). The conclusion is
that neutrophils somehow quench the BL of E. coli-lux either by absorbing the emission or by binding the
bacteria, thus altering the BL properties.
The second exception was the reduction of CFU values caused by 0.4% serum (Figure 3(b)).
Complement compounds present in this low serum concentration were transferred with the E. coli-lux cells
into the plates and continued their activity during the overnight incubation, causing a considerable reduction
in the bacterial viability in the plates. We have described this phenomenon earlier [29].
The lysis of the target E. coli-lux cells in the presence of H2O2 and/or HOCl was observed as a
reduction in OD signal (Figure 2). These agents caused a rapid loss in viability (RLU values in Figures 1(a)
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and 2 and CFU values in Figure 1(b)) followed by much slower gradual lysis of the E. coli-lux (Figure 2).
We will further study what are the mechanisms lying behind H2O2- and HOCl-induced lysis.
When the luminol-ampliﬁed CL assay (MPO release) was compared with viability assays, the
maximum rate of the MPO release (the peak CL) coincided with the onset of the killing, suggesting that a
certain threshold concentration of HOCl must be achieved before killing starts.
The results of this study suggest that the viability of E. coli-lux can be assessed on a real-time basis
quickly and efﬁciently without tedious and time-consuming plate counting.
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